GlassScriptPhysician profile
John S Hostetler
NPI 1871654657
$1,464.18
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,015 · 2020: $128 · 2021: $90.41 · 2022: $46.65 · 2023: $123 · 2024: $61.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $184.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $241.08 | 2019-2024 | Cabenuva |
| Gilead Sciences, INC. | $215.89 | 2019-2023 | |
| Tetraphase Pharmaceuticals, INC. | $123.83 | 2019 | |
| Janssen Biotech, INC. | $105.36 | 2019-2021 | |
| Sanofi Pasteur INC. | $103.43 | 2019 | |
| Janssen Products, LP | $99.95 | 2019 | |
| Merck Sharp & Dohme LLC | $92.44 | 2019-2020 | |
| Melinta Therapeutics, LLC | $83.15 | 2019-2023 | Orbactiv, Kimyrsa, Vabomere |
| Abbvie INC. | $82.73 | 2019-2020 | |
| Daiichi Sankyo INC. | $46.50 | 2020-2022 | |
| Ucb, INC. | $39.68 | 2023 | |
| Theratechnologies INC. | $37.20 | 2019 | |
| Allergan, INC. | $34.80 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $31.71 | 2019 | |
| Pfizer INC. | $24.91 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $20.38 | 2023 | Octagam Immune Globulin (Human) |
| Horizon Therapeutics Plc | $17.85 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.62 | 2019 | |
| Insmed, INC. | $16.24 | 2020 | |
| Glaxosmithkline, LLC. | $15.93 | 2024 | Nucala |
| Kedrion Biopharma INC. | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hostetler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.